Salivary Melatonin Profile: How to Interpret Your Result

What the Salivary Melatonin Profile Actually Measures

The salivary melatonin profile does not simply record a single number. It captures the full shape of your nocturnal melatonin secretion curve, typically across 6 to 10 saliva samples collected at 30 or 60-minute intervals under strict dim-light conditions (<10 lux). Each sample reflects the free, unbound fraction of melatonin that diffuses from capillary blood into saliva within 5 to 10 minutes, making saliva a reliable, non-invasive proxy for plasma values at a roughly 2:1 to 3:1 plasma-to-saliva ratio. [1]

What DLMO Is and Why It Matters

Dim-light melatonin onset (DLMO) is the single most clinically informative variable in the report. It marks the time point at which salivary melatonin crosses a threshold (3 pg/mL by the standard 2SD method, or 25% of the individual's peak amplitude) while rising during the evening. [2] Because DLMO consistently precedes sleep onset by 2 to 3 hours in normally entrained adults, your clinician can use it to calculate your circadian phase angle and determine whether your internal clock is running early, on time, or late relative to your desired sleep window.

How the Profile Differs From a Single-Point Melatonin Test

A single midnight serum or saliva sample tells you only whether melatonin was present at that moment. It cannot identify whether onset was delayed by three hours, whether the curve was blunted across the whole night, or whether you experienced an abnormally early offset (the point at which levels fall back below threshold in the early morning). The profile gives your clinician all three: onset time, peak amplitude, and offset time.

Sample Collection Conditions That Change the Result

Light exposure above 10 lux can suppress melatonin acutely; a single overhead fluorescent lamp at reading distance delivers roughly 200 to 500 lux. Patients who collect samples under normal indoor lighting will produce artificially suppressed curves that mimic phase disorders. Your lab report should state the lux level used during collection. If it does not, treat the values with caution and request a repeat under verified dim-light conditions.

Normal Salivary Melatonin Ranges

Normal ranges vary by age, sex, and the specific immunoassay platform used by the laboratory, but published reference intervals from multiple validation studies cluster around the following values. [3]

DLMO Threshold Reference Values

The Endocrine Society's clinical practice guideline on circadian rhythm sleep-wake disorders cites a DLMO threshold of 3 pg/mL (salivary) as the standard 2SD criterion for adults. [2] Some laboratories use 4 pg/mL or the 25%-of-peak method, which produces slightly earlier onset times but correlates equally well with polysomnographic sleep onset. An onset time between 21:00 and 23:00 local clock time is typical for adults who sleep between 23:00 and 01:00.

Peak Amplitude Ranges by Age

• Ages 20 to 40: peak salivary melatonin typically 10 to 60 pg/mL
• Ages 40 to 60: peak salivary melatonin typically 8 to 40 pg/mL
• Ages 60 and older: peak salivary melatonin commonly 5 to 25 pg/mL, with a flattened curve

A study of 107 healthy volunteers (mean age 38 years) published in the Journal of Pineal Research found mean peak salivary melatonin of 21.4 pg/mL (SD 12.8), with high inter-individual variability confirming that absolute amplitude alone is less diagnostically useful than phase timing. [3]

Daytime Baseline

Daytime values (08:00 to 18:00) should be at or below 1 to 2 pg/mL. A daytime salivary reading above 3 pg/mL warrants investigation for exogenous melatonin carry-over, phase-advanced circadian rhythm disorder, or, rarely, a pinealoma. [4]

What a Low Salivary Melatonin Result Means

A low result is defined as either a DLMO that is absent or falls more than 2 hours later than expected for your target sleep time, a peak amplitude below 5 pg/mL, or both. [2]

Delayed Sleep Phase Disorder

Delayed sleep phase disorder (DSPD) is the most common diagnosis associated with a late DLMO. Patients with DSPD typically show a DLMO after midnight when they want to fall asleep before 23:00. A 2019 review in Sleep Medicine Reviews analyzed data from 341 DSPD patients and found their mean DLMO was 02:14 compared to 22:48 in controls, a phase delay of more than 3 hours. [5] Patients often describe lying awake for hours despite feeling tired, then sleeping well once they finally fall asleep late.

Suppressed Amplitude Without Phase Delay

Some patients show a DLMO at the normal clock time but a peak amplitude below 5 pg/mL. This pattern suggests melatonin secretion is starting on schedule but is being actively suppressed. Common causes include:

• Chronic blue-light exposure from screens after 20:00
• Beta-blocker use (propranolol, atenolol), which reduces nocturnal melatonin by 40 to 75% [6]
• NSAID use, particularly aspirin and ibuprofen, which may blunt nocturnal secretion by inhibiting prostaglandin pathways [7]
• Alcohol consumption within 3 hours of bedtime
• High BMI (body mass index above 30), associated with lower amplitude in several cross-sectional studies [8]

Age-Related Decline

After age 40, pineal calcification and reduced noradrenergic input to the pineal gland reduce melatonin output progressively. Adults older than 60 frequently show peak amplitudes below 10 pg/mL; this is a physiological finding, not necessarily a pathological one, unless accompanied by severe insomnia or circadian misalignment symptoms.

What a High Salivary Melatonin Result Means

A high result is defined as a daytime value above 3 pg/mL, a peak above 100 pg/mL, or a DLMO that falls before 19:00. [4]

Advanced Sleep Phase Disorder

Advanced sleep phase disorder (ASPD) produces a DLMO 3 or more hours earlier than the population mean, often falling between 17:00 and 20:00. Affected individuals feel compelled to fall asleep by 20:00 and wake spontaneously at 03:00 to 05:00. ASPD is more common after age 60 and has been linked to mutations in the PER2 and CKIδ clock genes. [9]

Exogenous Melatonin Carry-Over

Over-the-counter melatonin supplements sold in the United States range from 0.5 mg to 10 mg, with some products tested by ConsumerLab.com measuring actual content up to 478% higher than labeled. [10] A patient who took a 5 mg tablet the prior evening may still show elevated salivary melatonin the following morning, producing a falsely elevated daytime reading. Your lab report should ask about supplement use in the 24 hours before collection.

Rare Pathological Causes

Pineal gland tumors (pinealomas) can produce tonically elevated melatonin across both day and night. If a result shows melatonin above 100 pg/mL at multiple daytime time points, imaging of the pineal region is warranted. This presentation is rare, with pineal tumors accounting for only 1% of all intracranial neoplasms. [4]

How to Lower a High Salivary Melatonin Level

Reducing abnormally elevated melatonin or correcting a phase-advanced pattern requires targeting either the light-dark cycle or the underlying supplementation habit.

Light Therapy in the Evening

Bright-light therapy delivered in the early evening (18:00 to 21:00) at 2,500 to 10,000 lux for 30 to 60 minutes can delay a phase-advanced DLMO by 1 to 2 hours within 1 to 2 weeks. [2] The American Academy of Sleep Medicine (AASM) recommends timed light exposure as first-line treatment for ASPD in its clinical practice guidelines. Patients should use a calibrated lightbox rather than a lamp; distance and angle significantly affect lux delivery.

Stopping or Reducing Exogenous Melatonin

If carry-over from supplements is confirmed, stopping the supplement for 5 to 7 days before repeating the test is the simplest intervention. If melatonin is prescribed therapeutically, switching to a physiological dose of 0.5 mg timed release taken at 21:00 rather than a pharmacological 5 to 10 mg dose may normalize the endogenous profile more accurately. [11]

How to Raise a Low Salivary Melatonin Level

Raising a suppressed or delayed melatonin profile is the more common clinical challenge, especially in shift workers, DSPD patients, and older adults.

Melatonin Supplementation Timing and Dose

The goal is not simply to increase amplitude; phase-advancing a late DLMO requires precise timing. Exogenous melatonin taken 5 to 6 hours before the current DLMO shifts the clock forward by roughly 1 to 2 hours per administration cycle. [2] A dose of 0.5 mg is pharmacologically sufficient for phase shifting; higher doses (3 to 5 mg) sedate but do not produce proportionally greater phase shifts and may cause morning grogginess. [11]

A randomized controlled trial by Mundey et al. (N=24) demonstrated that 0.5 mg melatonin timed to the individual's DLMO minus 5 hours advanced DLMO by a mean of 1.5 hours over 4 weeks, outperforming placebo by a statistically significant margin (P<0.01). [11]

Blue-Light Blocking and Evening Light Reduction

Wearing blue-light-blocking glasses (amber lenses, >90% attenuation of 480 nm wavelengths) starting 2 hours before target bedtime has been shown to increase endogenous melatonin amplitude by 58% compared to clear lenses in a crossover trial by Burkhart and Phelps (N=20). [12] Turning off overhead lighting and relying on dim, warm-tone lamps after 20:00 produces a similar benefit at lower cost.

Addressing Medication-Induced Suppression

If a beta-blocker is suppressing melatonin, switching from a non-selective agent (propranolol) to a cardioselective agent (atenolol, bisoprolol) may reduce the suppression effect, though cardioselective agents still cause some reduction. [6] Any medication adjustment requires approval and supervision from the prescribing clinician. Do not stop a beta-blocker without medical guidance.

Consistency of Sleep-Wake Schedule

Irregular sleep schedules fragment the circadian zeitgeber signal. A meta-analysis of 18 studies (N=9,212) found that social jet lag of 2 or more hours between weekday and weekend sleep timing was associated with a 28% lower melatonin amplitude compared to individuals with <1-hour social jet lag. [13] Fixing a consistent wake time 7 days per week is the most accessible single intervention for gradually normalizing DLMO.

Factors That Affect Salivary Melatonin Results

The table below summarizes the main variables that shift salivary melatonin values and the approximate magnitude of each effect, based on published literature.

| Factor | Direction of Effect | Approximate Magnitude | |---|---|---| | Blue-light exposure (480 nm) after 20:00 | Suppresses amplitude, delays DLMO | 40 to 80% amplitude reduction [12] | | Propranolol (beta-blocker) | Suppresses amplitude | 40 to 75% reduction [6] | | Aspirin / ibuprofen chronic use | Suppresses amplitude | 10 to 30% reduction [7] | | Alcohol (2+ drinks within 3 h of sleep) | Suppresses amplitude, fragments curve | 15 to 20% reduction [8] | | Age >60 | Reduces amplitude | 50 to 70% lower than young adults [3] | | BMI >30 | Reduces amplitude | 20 to 35% lower vs. Normal BMI [8] | | Exogenous melatonin (5 to 10 mg) | Elevates values, may delay endogenous onset | 200 to 500% above endogenous peak [10] | | Consistent 7-day wake time | Increases amplitude, advances DLMO | 15 to 25% amplitude increase [13] |

How Clinicians Use the Profile to Guide Treatment

A salivary melatonin profile on its own rarely produces a final treatment decision. Clinicians integrate it with sleep diary data (minimum 2 weeks), actigraphy output, and patient history.

Circadian Phase Disorder Diagnosis

The Endocrine Society's 2015 clinical practice guideline states: "We recommend measuring DLMO by salivary or plasma melatonin for the diagnosis of circadian rhythm sleep-wake disorders when the timing of melatonin administration or light therapy needs to be individualized." [2] This means the profile is the gold standard for planning personalized intervention timing, not just confirming that a disorder exists.

Shift-Work Planning

For rotating shift workers, a profile taken at the start of a new shift rotation identifies how far the internal clock has drifted from the required work schedule. Night-shift workers typically show a DLMO between 05:00 and 09:00 after sufficient adaptation, a full inversion of the normal pattern. Knowing this allows scheduling of strategic naps, melatonin dosing, and light therapy breaks within the shift to minimize performance impairment.

Melatonin Replacement in Older Adults

Older adults with insomnia and documented low-amplitude profiles (<5 pg/mL peak) may benefit from low-dose melatonin replacement (0.5 to 2 mg prolonged-release formulations) timed to their individual DLMO. A Cochrane review of 19 randomized trials found that melatonin modestly reduced sleep-onset latency by a mean of 7.06 minutes (95% CI: 2.17 to 11.95) and improved subjective sleep quality, with effects most pronounced in patients with confirmed circadian phase disorders rather than primary insomnia of psychological origin. [14]

Getting the Most Accurate Test Result: Collection Tips

• Collect samples in a room lit only by a single 7-watt incandescent bulb or a dedicated dim-light lamp verified at <10 lux with a phone lux-meter app.
• Do not eat, drink (except plain water), or brush teeth for 30 minutes before each sample.
• Stop any melatonin supplements at least 5 to 7 days before the test.
• Record exact sample times, not approximate times. A 20-minute error in sample time can misplace DLMO by one time-point.
• Keep samples frozen at -20°C immediately after collection if the kit requires it; melatonin degrades rapidly at room temperature in saliva.